164 related articles for article (PubMed ID: 20390307)
41. Modification of alpha-adrenoceptor-mediated pressor responses by NG-nitro-L-arginine methyl ester and vasopressin in endotoxin-treated pithed rats.
Guc MO; Furman BL; Paratt JR
Eur J Pharmacol; 1992 Nov; 224(1):63-9. PubMed ID: 1280596
[TBL] [Abstract][Full Text] [Related]
42. Comparison between selective and nonselective nitric oxide synthase inhibition and phenylephrine in normal and endotoxic swine.
Cohen RI; Shapir Y; Davis A; Loona R; Scharf SM
Crit Care Med; 2000 Sep; 28(9):3257-67. PubMed ID: 11008990
[TBL] [Abstract][Full Text] [Related]
43. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock.
Sennoun N; Montemont C; Gibot S; Lacolley P; Levy B
Crit Care Med; 2007 Jul; 35(7):1736-40. PubMed ID: 17522580
[TBL] [Abstract][Full Text] [Related]
44. Effects of nitric oxide synthase inhibition on regional blood flow in a porcine model of endotoxic shock.
Offner PJ; Robertson FM; Pruitt BA
J Trauma; 1995 Aug; 39(2):338-43. PubMed ID: 7545764
[TBL] [Abstract][Full Text] [Related]
45. Involvement of nitric oxide in the regulation of regional hemodynamics in streptozotocin-diabetic rats.
Granstam E; Granstam SO
Physiol Res; 2003; 52(2):159-69. PubMed ID: 12678658
[TBL] [Abstract][Full Text] [Related]
46. Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on intrarenal diffusion and oxygenation measured by magnetic resonance imaging.
Hueper K; Hartung D; Gutberlet M; Gueler F; Sann H; Husen B; Wacker F; Reiche D
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1428-35. PubMed ID: 24005471
[TBL] [Abstract][Full Text] [Related]
47. Berberine restored nitrergic and adrenergic function in mesenteric and iliac arteries from streptozotocin-induced diabetic rats.
Zhao L; Liu S; Wang M; Zhi M; Geng X; Hou C; Wang W; Zhao D
J Ethnopharmacol; 2019 Nov; 244():112140. PubMed ID: 31400506
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat.
Ito A; Uriu K; Inada Y; Qie YL; Takagi I; Ikeda M; Hashimoto O; Suzuka K; Eto S; Tanaka Y; Kaizu K
J Lab Clin Med; 2001 Sep; 138(3):177-85. PubMed ID: 11528370
[TBL] [Abstract][Full Text] [Related]
49. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
Komers R; Allen TJ; Cooper ME
Diabetes; 1994 Oct; 43(10):1190-7. PubMed ID: 7926287
[TBL] [Abstract][Full Text] [Related]
50. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
[TBL] [Abstract][Full Text] [Related]
51. L-arginine augments nitric oxide production and mesenteric blood flow in ovine endotoxemia.
Allman KG; Stoddart AP; Kennedy MM; Young JD
Am J Physiol; 1996 Oct; 271(4 Pt 2):H1296-301. PubMed ID: 8897920
[TBL] [Abstract][Full Text] [Related]
52. Regional changes in constitutive nitric oxide synthase and the hemodynamic consequences of its inhibition in lipopolysaccharide-treated pigs.
Javeshghani D; Magder S
Shock; 2001 Sep; 16(3):232-8. PubMed ID: 11531027
[TBL] [Abstract][Full Text] [Related]
53. The effect of vasopressin on organ blood flow in an endotoxin-induced rabbit shock model.
Kang CH; Kim WG
J Invest Surg; 2006; 19(6):361-9. PubMed ID: 17101605
[TBL] [Abstract][Full Text] [Related]
54. The effect of 17beta-oestradiol on regional blood flow in anaesthetized pigs.
Vacca G; Battaglia A; Grossini E; Mary DA; Molinari C; Surico N
J Physiol; 1999 Feb; 514 ( Pt 3)(Pt 3):875-84. PubMed ID: 9882757
[TBL] [Abstract][Full Text] [Related]
55. Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats.
Varagic J; Jerkic M; Jovovic D; Nastic-Miric D; Adanja-Grujic G; Markovic-Lipkovski J; Lackovic V; Radujkovic-Kuburovic G; Kentera D
Am J Med Sci; 2000 Sep; 320(3):171-6. PubMed ID: 11014370
[TBL] [Abstract][Full Text] [Related]
56. Differential renal response to Nomega-nitro-L-arginine methyl ester and L-arginine in rats with hypertensive or diabetic nephropathy.
Erley CM; Heyne N; Friedrich B; Schmidt T; Strobel U; Wehrmann M; Osswald H
J Cardiovasc Pharmacol; 2002 Nov; 40(5):780-8. PubMed ID: 12409987
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
58. Hemodynamic response to norepinephrine with and without inhibition of nitric oxide synthase in porcine endotoxemia.
Datta P; Magder S
Am J Respir Crit Care Med; 1999 Dec; 160(6):1987-93. PubMed ID: 10588618
[TBL] [Abstract][Full Text] [Related]
59. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
60. Contribution of endothelial nitric oxide synthase in the blunted renal responses to volume expansion in diabetic rats.
Wongmekiat O; Johns E
Exp Physiol; 2001 Jul; 86(4):481-8. PubMed ID: 11445827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
